Globus Medical Inc - A (GMED) 13F Ownership Report (Q2 2026)

GMED ranks #946 out of 37696 tracked stocks by institutional interest — one of the most closely watched names in our coverage.

605 institutions disclose a position in GMED, but none treat it as a major bet — even Global Alpha Capital Management Ltd., its most concentrated holder, allocates just 4.1% of its own portfolio to it.

Fort Washington Investment Advisors Inc /oh/ has added to its GMED position for two straight quarters, increasing it by $3.1M to reach $33.8M today.

Artemis Investment Management LLP has trimmed its GMED position for two straight quarters, cutting it by $32.5M while still holding $40.6M.

GMED is up 3.3% today, and institutions have been net buyers of $1.7B this quarter — today's price move and the underlying institutional flow are pointing the same direction.

GMED posted net income of $535.4M over the trailing twelve months, and currently trades at a P/E of 20.2.

• Profitable — net income of $535.4M over the trailing twelve months
• Revenue grew 19.7% year over year
• Net income improved year over year, from $356.6M to $535.4M
• Generated $753.4M in positive operating cash flow
• Current ratio of 4.26x — enough short-term assets to cover short-term liabilities
• Liabilities run 0.16x equity — within a conventional range